Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 4,838 | 4,953 | 7,122 | 8,709 | 7,983 |
| Cost of Goods | 3,186 | 2,940 | 3,421 | 4,000 | 3,837 |
| Gross Profit | 1,652 | 2,013 | 3,701 | 4,709 | 4,146 |
| Operating Expenses | 17,124 | 35,390 | 34,801 | 33,127 | 34,395 |
| Operating Income | -15,286 | -32,437 | -30,679 | -28,418 | -29,412 |
| Interest Expense | 3,379 | 4,371 | 3,396 | 3,386 | 2,784 |
| Other Income | -79 | -560 | 7,898 | -475 | -255 |
| Pre-tax Income | -18,744 | -37,368 | -26,177 | -32,279 | -32,451 |
| Net Income Continuous | -18,744 | -37,368 | -26,177 | -32,279 | -32,451 |
| Net Income | $-18,744 | $-37,368 | $-26,177 | $-32,279 | $-32,451 |
| EPS Basic Total Ops | -2.07 | -0.48 | -0.39 | -0.55 | -0.61 |
| EPS Basic Continuous Ops | -2.00 | -0.46 | -0.39 | -0.55 | -0.61 |
| EPS Diluted Total Ops | -2.07 | -0.48 | -0.39 | -0.55 | -0.61 |
| EPS Diluted Continuous Ops | -2.00 | -0.46 | -0.39 | -0.55 | -0.61 |
| EBITDA(a) | $-13,214 | $-30,438 | $-28,156 | $-26,555 | $-27,846 |